Key result
Early pulsed field ablation is linked to improved 1-year arrhythmia-free survival vs later intervention.
Why the study?
The impact of timing of first-line pulsed field ablation on 1-year arrhythmia-free survival in AF patients was unclear.
Does early pulsed field ablation (<12 months from AF diagnosis) improve 1-year arrhythmia-free survival in patients with atrial fibrillation compared with later ablation?
Cohort
Does early pulsed field ablation (<12 months from AF diagnosis) improve 1-year arrhythmia-free survival in patients with atrial fibrillation compared with later ablation?
Performing pulsed field ablation within 12 months of atrial fibrillation diagnosis improves 1-year arrhythmia-free survival, supporting an upfront interventional rhythm control strategy.
Answers are grounded in this paper and cite their sources.
May support early pulsed field ablation in atrial fibrillation; leaves open whether randomized trials confirm timing benefits.
Key Findings• Early PFA ablation (<12 months from AF diagnosis) was associated with improved 1year arrhythmia-free survival compared with later ablation.• The benefit of early ablation was preserved in first-line patients without prior antiarrhythmic drug therapy, supporting an upfront interventional strategy.• Time from AF diagnosis and early recurrence were independent predictors of late recurrence.
No takes yet. Share an insight, caveat, or question.
Yogarajah et al. (2026) conducted a cohort in Atrial Fibrillation. Early pulsed field ablation (PFA) (<12 months from diagnosis) vs. Late ablation was evaluated on 1-year arrhythmia-free survival. Early pulsed field ablation (<12 months from AF diagnosis) was associated with improved 1-year arrhythmia-free survival compared with later ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: